257 related articles for article (PubMed ID: 28093948)
1. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
3. Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity.
Wan Y; Moyle PM; Christie MP; Toth I
Nanomedicine (Lond); 2016 Apr; 11(8):907-19. PubMed ID: 26979574
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
6. Integration of Cell-Penetrating Peptides with Rod-like Bionanoparticles: Virus-Inspired Gene-Silencing Technology.
Tian Y; Zhou M; Shi H; Gao S; Xie G; Zhu M; Wu M; Chen J; Niu Z
Nano Lett; 2018 Sep; 18(9):5453-5460. PubMed ID: 30091612
[TBL] [Abstract][Full Text] [Related]
7. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.
Chen B; Pan R; Askhatova D; Chen P
Int J Nanomedicine; 2015; 10():3303-14. PubMed ID: 25999710
[TBL] [Abstract][Full Text] [Related]
8. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
Toriyabe N; Hayashi Y; Harashima H
Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
[TBL] [Abstract][Full Text] [Related]
9. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
10. Design of a multicomponent peptide-woven nanocomplex for delivery of siRNA.
Jun E; Kim S; Kim JH; Cha K; So IS; Son HN; Lee BH; Kim K; Kwon IC; Kim SY; Kim IS
PLoS One; 2015; 10(2):e0118310. PubMed ID: 25705892
[TBL] [Abstract][Full Text] [Related]
11. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
13. EGFP-Based Protein Nanoparticles with Cell-Penetrating Peptide for Efficient siRNA Delivery.
Guan X; Hu X; Cui F; Li Y; Jing X; Xie Z
Macromol Biosci; 2015 Nov; 15(11):1484-9. PubMed ID: 26109167
[TBL] [Abstract][Full Text] [Related]
14. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
Katas H; Abdul Ghafoor Raja M; Ee LC
Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
Zhang C; Yuan W; Wu Y; Wan X; Gong Y
Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
[TBL] [Abstract][Full Text] [Related]
16. Delivery of siRNA Using Cationic Liposomes Incorporating Stearic Acid-modified Octa-Arginine.
Yang D; Li Y; Qi Y; Chen Y; Yang X; Li Y; Liu S; Lee RJ
Anticancer Res; 2016 Jul; 36(7):3271-6. PubMed ID: 27354583
[TBL] [Abstract][Full Text] [Related]
17. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
18. Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems.
Begum AA; Toth I; Moyle PM
Nanomedicine (Lond); 2019 May; 14(9):1153-1171. PubMed ID: 31050581
[No Abstract] [Full Text] [Related]
19. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide.
Nakamura M; Fujiwara K; Doi N
J Nanobiotechnology; 2022 Oct; 20(1):458. PubMed ID: 36303212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
